Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of GRN163L in Combination With Paclitaxel and Bevacizumab in Patients With Locally Recurrent or Metastatic Breast Cancer

NCT00732056 is registered in ClinicalTrials.gov with Geron Corporation as lead sponsor.

NCT NCT00732056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00732056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of GRN163L in Combination With Paclitaxel and Bevacizumab in Patients With Locally Recurrent or Metastatic Breast Cancer
Lead sponsor
Geron Corporation
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2008
Completion date
March 31, 2012
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer